Synergies and Impact
QuantOCancer will build research capacity at the Champalimaud Foundation and increase the attractiveness of the Lisbon region to international researchers, but overall project impacts are expected far beyond this: on research infrastructures and initiatives, on future health challenges and on international policy.
Added value to existing (and future) regional, national and international initiatives
Through the establishment of alliances between QuantOCancer and regional, national and international initiatives, a maximisation of resources will be achieved. For example, QuantOCancer will synergise with existing national research infrastructures (including CONGENTO, Biodata.pt and Portuguese Platform for Bioimaging (PPBI)) and European initiatives (including clinical and translational projects - UM-CURE 2020, BOUNCE), H2020 MSCA Innovative Training Networks (ITNs) such as ELBA, and European Research Council (ERC) grants. The cementing and expansion of networks of collaborations will be key in increasing capabilities to secure internationally competitive funding.
Consortium of Genetically Tractable Organisms
CF Contacts: Rui Costa, João Cruz
Portuguese Biological Data Network
CF Contact: Pedro Garcia da Silva
Predicting effective adaptation to breast cancer to help women to BOUNCE back
CF Contacts: Fatima Cardoso, Berta Sousa
New therapies for uveal melanoma
CF Contact: Antonio Parreira
European Liquid Biopsies Academy
CF Contact: Bruno Costa-Silva
